AURANOFIN THERAPY AND QUALITY-OF-LIFE IN PATIENTS WITH RHEUMATOID-ARTHRITIS - RESULTS OF A MULTICENTER TRIAL

被引：357

作者：

BOMBARDIER, C

WARE, J

RUSSELL, IJ

LARSON, M

CHALMERS, A

READ, JL

机构：

来源：

关键词：

D O I：

10.1016/0002-9343(86)90539-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：565 / 578

页数：14

共 62 条

[1] [Anonymous], 1960, ANN RHEUM DIS, V19, P95
[2] BALABAN DJ, MED CARE
[3] THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE
BERGNER, M
BOBBITT, RA
CARTER, WB
GILSON, BS
[J]. MEDICAL CARE, 1981, 19 (08) : 787 - 805
[4] AURANOFIN - A UNIQUE ORAL CHRYSOTHERAPEUTIC AGENT
BLODGETT, RC
HEUER, MA
PIETRUSKO, RG
[J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1984, 13 (03) : 255 - 273
[5] BOMBARDIER C, 1985, J RHEUMATOL, V12, P403
[6] BOMBARDIER C, 1982, J RHEUMATOL, V9, P798
[7] BOMBARDIER C, 1983, J RHEUMATOL, V10, P68
[8] BOMBARDIER C, UNPUB COMPARISON CLI
[9] BROOK RH, 1979, MED CARE S7, V17, P95
[10] THE DIMENSIONS OF HEALTH OUTCOMES - A CROSS-VALIDATED EXAMINATION OF HEALTH-STATUS MEASUREMENT
BROWN, JH
KAZIS, LE
SPITZ, PW
GERTMAN, P
FRIES, JF
MEENAN, RF
[J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1984, 74 (02) : 159 - 161